ClinConnect ClinConnect Logo
Dark Mode
Log in

Case Study: Risk-Calibrated RBQM, CTMS/IWRS & Alzheimer Ops

Case Study: Risk-Calibrated RBQM, CTMS/IWRS & Alzheimer Ops
A practical case study tour: how sponsors, research site administrators and caregivers partnered in 2024–2025 to run more efficient, patient-centered trials across oncology, obesity and Alzheimer research.

1. Risk-calibrated RBQM for multicenter oncology trials

Risk-calibrated RBQM for multicenter oncology trials moved from theory to practice in 2024–2025, with sponsors prioritizing analytics-driven monitoring that focuses on the highest clinical and data risks rather than one-size-fits-all site visits. Research site administrators reported fewer low-value source-data queries and clearer escalation paths for adverse events, helping teams keep patient safety front and center while conserving monitoring bandwidth.

2. Lean site activation workflows with CTMS/IWRS integration

Lean site activation workflows with CTMS/IWRS integration shortened the timeline between site selection and first patient in by aligning regulatory milestones, kit provisioning and enrollment calendars. Integrations reduced redundant data entry for site staff and allowed real-time visibility into drug supply and randomization status, so administrators could coordinate training and screen potential participants more predictably.

What changed operationally

Sponsors leaned on automated triggers and centralized dashboards to flag missing documents, and sites used the same CTMS/IWRS feed to confirm kits were ready when candidates walked in — a simple change that reduced last-minute delays seen in many 2024–2025 multicenter studies.

3. Targeted obesity cohort recruitment and retention playbook

Targeted obesity cohort recruitment and retention playbook tactics focused on precision outreach, flexible visit windows and value-added retention touches like transportation or nutritional counseling tele-visits. Community-informed messaging and culturally competent outreach increased screening yield. Research site administrators noted that retention improved when protocols built in remote check-ins and easy access to trial coordinators via brief video calls.
Caregiver voice: "Scheduling around my work and my brother's appointments used to be impossible. The study team offered evening remote visits and a single in-person screening that made it possible for us to join and continue."

4. Decentralized healthy-volunteer operations for Alzheimer biomarkers

Decentralized healthy-volunteer operations for Alzheimer biomarkers combined home-based biospecimen collection, mobile phlebotomy and remote cognitive screening to broaden access to asymptomatic cohorts. 2024–2025 data demonstrated feasibility: sites that piloted decentralized workflows saw faster enrollment of geographically diverse volunteers and fewer no-shows. Caregivers and family members of volunteers valued the reduced travel burden and clearer communication about what biomarker results would — and would not — mean for health.

5. Cross-cutting lessons for research site administrators and sponsors

Across indications, three themes stood out: risk-focused monitoring that preserves safety oversight, integrated operational stacks that remove administrative friction, and participant-first logistics that keep caregivers and volunteers in mind. Platforms like ClinConnect are making it easier for patients to find trials that match their specific needs, while site teams benefit from better-ready participants and streamlined scheduling.
  • What are the study’s major risks and how will they be monitored?
  • How flexible are visit windows and are remote options available?
  • What support is available for caregivers (transport, scheduling, communications)?
  • How will biomarker samples be collected and how are results communicated?
  • Who is my main point of contact at the research site and how do I reach them?
Final thought: combining risk-calibrated RBQM, CTMS/IWRS-enabled site workflows, targeted recruitment playbooks and decentralized volunteer operations creates trials that respect participant time, reduce site burden, and generate higher-quality data — and caregivers and site teams are the real architects of that success.

Related Articles

x- x- x-